Clinical Trial

Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Gastric Cancer

Study acronym: G-PEC
Recruiting
View on ClinicalTrials.gov →
Summary
The study investigates the outcomes of hyperthermic intraperitoneal chemoperfusion (HIPEC) in combination with curative-intent gastrectomy in resectable locally-advanced and limited-metastatic (low peritoneal cancer index) gastric cancer.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-21.
Trial Details
NCT Number NCT07313579
Lead Sponsor Ukrainian Society of Clinical Oncology
Conditions Gastric Cancer (GC), HIPEC, Peritoneal Metastases From Gastric Cancer, Hyperthermic Intraperitoneal Chemoperfusion
Enrollment 200 participants
Start Date 2025-12-01
Primary Completion 2030-12-01 (estimated)
Study Completion 2035-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-13